Evidence map›Paper›PMID 39567460›Full record

ReviewNeuropsychology review2025

Measurement Error and Methodologic Issues in Analyses of the Proportion of Variance Explained in Cognition.

Emma Nichols, Vahan Aslanyan, Tamare V Adrien, Ryan M Andrews, David W Fardo, Brandon E Gavett, Theone S E Paterson, Indira C Turney, Christina B Young, James O Uanhoro and 2 more

Abstract readReview
In one paragraph

Review in Neuropsychology review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emma NicholsCenter for Economic and Social Research, University of Southern California, VPD, 635 Downey Way, Los Angeles, CA, 90089, USA. emmanich@usc.edu.ORCID http://orcid.org/0000-0002-9005-3872
Vahan AslanyanDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, 1845 N. Soto St, Los Angeles, CA, 90032, USA.
Tamare V AdrienDepartment of Clinical and Health Psychology, University of Florida, 1225 Center Dr, Gainesville, FL, 32603, USA.
Ryan M AndrewsDepartment of Epidemiology, School of Public Health, Boston University, 715 Albany St, Boston, MA, 02118, USA.
David W FardoDepartment of Biostatistics, Sanders-Brown Center On Aging, Lexington, KY, 40536, USA.
Brandon E GavettDepartment of Neurology, University of California Davis School of Medicine, Sacramento, CA, 95816, USA.
Theone S E PatersonDepartment of Psychology, University of Victoria, Victoria, BC, V8W 2Y2, Canada.
Indira C TurneyTaub Institute for Research On Alzheimers Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA.
Christina B YoungDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, 213 Quarry Road, Palo Alto, CA, 94304, USA.
James O UanhoroDepartment of Educational Psychology, University of North Texas, 1300 W. Highland Street Denton, Denton, TX, 76203, USA.
Alden L GrossDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21231, USA.
For The Alzheimer's Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Integrting Information About Aging SurveysR01AG030153 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Sara Adar, Alden L. Gross · 2007 to 2026
$41.7M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Audrey Peiwen Fan · 2021 to 2026
$25.2M
Socioeconomic, Cardiovascular, and Psychosocial Sources of Cross-National Variation in Cognitive Health Among Older AdultsR01AG070953 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alden L. Gross, Lindsay C Kobayashi · 2021 to 2026
$4.6M
Genetic Architecture of Pure Alzheimer's Disease and Mixed PathologyR01AG082730 · NIA · UNIVERSITY OF WASHINGTON · PI David William Fardo, Shubhabrata Mukherjee · 2023 to 2026
$4.0M
Biomarkers of neurodegeneration in the US and India: A cross-national evaluation of the biological underpinnings of ADRDRF1AG088003 · NIA · JOHNS HOPKINS UNIVERSITY · PI CRIMMINS, EILEEN M, GROSS, ALDEN L. · 2024 to 2024
$2.4M
Air pollution and noise exposures in relation to dementia: from brain imaging markers to clinical diseaseR01AG065359 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WEUVE, JENNIFER · 2020 to 2023
$2.3M
Genetic Architecture of Aging-Related TDP-43 and Mixed Pathology DementiaRF1AG082339 · NIA · UNIVERSITY OF KENTUCKY · PI FARDO, DAVID WILLIAM, NELSON, PETER T. · 2023 to 2023
$1.7M
Conference on Advanced Psychometric Methods in Cognitive Aging ResearchR13AG030995 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MUNGAS, DAN M. · 2008 to 2022
$620k
Regional tau deposition and digital assessment of cognition in preclinical AD and MCIK99AG071837 · NIA · STANFORD UNIVERSITY · PI YOUNG, CHRISTINA B · 2022 to 2023
$256k
Conference on Advanced Psychometric Methods in Cognitive Aging ResearchR13AG085953 · NIA · JOHNS HOPKINS UNIVERSITY · PI Alden L. Gross · 2024 to 2026
$150k
Alzheimer's Association AARFD-21-849349Michael Smith Health Research BC SCH-2022-2664NIA NIH HHS K99 AG071837NIA NIH HHS K99AG071837NIA NIH HHS P30 AG072972NIA NIH HHS R01 AG030153NIA NIH HHS R01AG030153NIA NIH HHS R01 AG065359NIA NIH HHS R01AG065359NIA NIH HHS R01 AG070953NIA NIH HHS R01AG070953NIA NIH HHS R01 AG082730NIA NIH HHS R01AG082730NIA NIH HHS R13 AG030995NIA NIH HHS R13AG030995NIA NIH HHS R13 AG085953NIA NIH HHS RF1 AG082339NIA NIH HHS RF1 AG088003NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Existing studies examining the predictive ability of biomarkers for cognitive outcomes do not account for variance due to measurement error, which could lead to under-estimates of the proportion of variance explained. We used data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (N = 1084) to estimate the proportion of variance explained by Alzheimer's disease (AD) imaging biomarkers in four cognitive outcomes: memory, executive functioning, language, and visuospatial functioning. We compared estimates from standard models that do not account for measurement error, and multilevel models that do account for measurement error. We also examined estimates across diagnostic subgroups (normal, MCI, AD). Estimates of the proportion of variance explained from multilevel models accounting for measurement error were larger (e.g., for language, 9-47% vs. 7-34% under standard modeling), with relatively greater differences between standard and multilevel measurement models for cognitive outcomes that have larger measurement error variance. Heterogeneity across subgroups also emphasized the importance of sample composition. Future studies should evaluate measurement error adjustments when considerable measurement error in cognitive outcomes is suspected.

Indexed as

Alzheimer DiseaseCognitionCognitive DysfunctionAgedBiomarkersExecutive FunctionFemaleHumansMaleNeuroimagingNeuropsychological TestsBiomarkersBiasBiomarkersCognitionDementiaMeasurement

Identifiers

PMID39567460
PMCPMC12089424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.